Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2006

View Archived Issues

CP-724714 pharmacokinetics assessed in humans and population model

Pharmacokinetics of KS-01017 formulations and administration routes compared

Receptor occupancy, pharmacokinetics and safety of lecozotan forms investigated

Miraxion improves stress hormone transport through the blood-brain barrier

DITPA studied in new phase II trial to treat elevated cholesterol levels

Targeting Ang-2 for inflammatory vasculopathies

Phase III trial investigates Ventavis with sildenafil citrate for PAH

Lilly studies enzastaurin for glioblastoma multiforme in new phase III study

X-Cell Medical begin new ETHOS drug-eluting stent trial

New phase I study for intravenous peramivir

Guidant studies fully bioabsorbable everolimus-eluting stent platform

New phase II trial investigates RG-2417 for bipolar depression

Traditional approval for Viread and Truvada

Novartis executes license option with Emisphere for oral PTH

Alchemia and Meditech Research announce merger

PK and tolerability of a new recombinant MCP-1 developed for limb ischemia

Positive phase I results for Pevion's malaria vaccine

PMA submission completed for Taxus Liberte paclitaxel-eluting coronary stent

Clinical application of LY-2124275 presented

Cervarix submitted for review in Europe

Fast track designation for ambrisentan

NicVAX awarded fast track designation

New antiinfective agents described in recent patents

Approvable letter for Preos

Daytrana NDA resubmission deemed Class I response

New anticancer agents revealed in recent patents

Paratek and Merck collaborate on novel antibiotic PTK-0796

Inhibition of Toll-like receptors, a promising approach for the treatment of lupus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...